Page last updated: 2024-12-08

phytenic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

phytenic acid: intermediate in conversion of phytol to phytanic acid; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12314226
CHEBI ID180283
MeSH IDM0133065

Synonyms (15)

Synonym
2-hexadecenoic acid, 3,7,11,15-tetramethyl-
(e,7r,11r)-3,7,11,15-tetramethylhexadec-2-enoic acid
22352-56-3
CHEBI:180283
2e-phytenoic acid
phytenic acid
LMPR0104010023
delta2-phytenic acid
3,7r,11r,15-tetramethyl-2e-hexadecenoic acid
phytenoic acid
3,7,11,15-tetramethyl-2-hexadecenoic acid
2-hexadecenoic acid, 3,7,11,15-tetramethyl-, (2e,7r,11r)-
HCY8333QWU ,
.delta.2-phytenic acid
unii-hcy8333qwu
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diterpenoidAny terpenoid derived from a diterpene. The term includes compounds in which the C20 skeleton of the parent diterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]